Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

Globally, gastric malignancy contributes to significant cancer-related morbidity and mortality. Despite a recent approval of two targeted agents, trastuzumab and ramucirumab, the treatment options for advanced-stage gastric cancer are limited. Consequently, the overall clinical outcomes for patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Vivek, Soni, Parita, Garg, Mohit, Kamholz, Stephan, Chandra, Abhinav B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146175/
https://www.ncbi.nlm.nih.gov/pubmed/30271341
http://dx.doi.org/10.3389/fphar.2018.00404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146175/
https://www.ncbi.nlm.nih.gov/pubmed/30271341
http://dx.doi.org/10.3389/fphar.2018.00404

Ejemplares similares